Frontlight ResearchEarly access
Not yet recruitingPhase 1
Budesonide absorption from different medicine forms, taken with or without food, in eosinophilic esophagitis
Compares how the body absorbs budesonide forms, with or without food, in adults.
Key facts
- Who runs it
- Dr. Falk Pharma GmbH
- Where
- Sweden1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- A clinical trial comparing how the body takes up budesonide from different forms of medicine when taken by mouth with or without food.
- Status
- Not yet recruiting
- Phase
- Phase 1
- People taking part
- 50 people, planned
- Started
- 23 Jul 2026
- Expected to end
- 30 Jun 2027
- Type of study
- Interventional
- Record updated
- 8 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults to study how the body takes up budesonide from different forms of the medicine. It is taken by mouth, with or without food. Healthy volunteers can join.
- Age
- 18 Years to 64 Years
- Sex
- All sexes can join.
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 64 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Plain-language title
- Budesonide absorption from different medicine forms, taken with or without food, in eosinophilic esophagitisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from 2025-522686-29-00, who can take part
- Record updated
- 8 October 2026